Gilead Sciences (GILD) has internally discussed potential split up - Bloomberg, citing EVP

September 7, 2016 11:13 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Gilead Sciences (NASDAQ: GILD) EVP of R&D said the company has discussed splitting-up internally, according to Bloomberg. Splitting up is not high on the list of the company's priorities, the executive said.

Gilead is always active in M&A, but not desperate. The company is open to all options, but would look for something sensible, according to today's commentary.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Management Comments, Spinoffs, Trader Talk

Add Your Comment